Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Jasnoor, Malhotra"'
Autor:
Nicholas J. Salgia, Alexander Chehrazi‐Raffle, JoAnn Hsu, Zeynep Zengin, Sabrina Salgia, Neal S. Chawla, Luis Meza, Jasnoor Malhotra, Nazli Dizman, Ramya Muddasani, Nora Ruel, Mary Cianfrocca, Jun Gong, Sidharth Anand, Victor Chiu, James Yeh, Sumanta K. Pal
Publikováno v:
Cancer Medicine, Vol 10, Iss 16, Pp 5671-5680 (2021)
Abstract Background Tertiary cancer centers offer clinical expertise and multi‐modal approaches to treatment alongside the integration of research protocols. Nevertheless, most patients receive their cancer care at community practices. A better und
Externí odkaz:
https://doaj.org/article/3247895c6c634ff285bccc140d3b7306
Autor:
Marcin Kortylewski, Nazli Dizman, Nicholas Salgia, Marice Alcantara, Luis Meza, Sabrina Salgia, Jasnoor Malhotra, Paulo Bergerot, Nora Ruel, Ewa Karczewska
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Circulating cytokines and angiogenic factors have been associated with clinical outcomes in patients with metastatic renal cell carcinoma (RCC) receiving systemic therapy. However, none have yet examined cytokine concentrations in parallel
Externí odkaz:
https://doaj.org/article/ec3a09751cf44ea391a9bc32406367a4
Autor:
Daniela V. Castro, Zeynep B. Zengin, Jasnoor Malhotra, Cristiane D. Bergerot, Luis Meza, Nazli Dizman, Ameish Govindarajan, JoAnn Hsu, Alex Chehrazi-Raffle, Neal Chawla, Benjamin D. Mercier, Sean W. Chen, Matthew Feng, Sweta Prajapati, Kyle O. Lee, Errol J. Philip, Tanya B. Dorff, Yung Lyou, Sumanta K. Pal
Publikováno v:
Cancer Investigation. 41:70-76
Since the approval of the COVID-19 vaccines, their safety and efficacy has been widely demonstrated in patients with cancer. However, there remain patients with reservations regarding vaccination. We aimed to assess genitourinary cancer patients' per
Autor:
Sumanta Pal, Nazli Dizman, JoAnn Hsu, Nicholas Salgia, Milton L Greenberg, Andrew C Newman, Jonathan Skupsky, Zeynep Zengin, Luis Meza, Neal Chawla, Sabrina Salgia, Jasnoor Malhotra
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/c7db408b55554bceb3ba79d95d5e6cbf
Publikováno v:
Cancer Treatment and Research Communications, Vol 24, Iss , Pp 100202- (2020)
Externí odkaz:
https://doaj.org/article/442f532c7c6a4c09b498d88e401d1307
Autor:
Daniela V. Castro, Jasnoor Malhotra, Luis Meza, Ameish Govindarajan, Errol J. Philip, Sumanta K. Pal
Publikováno v:
JACC: CardioOncology. 4:271-275
Autor:
Alexander Chehrazi-Raffle, Ramya Muddasani, Nazli Dizman, JoAnn Hsu, Luis Meza, Zeynep B. Zengin, Jasnoor Malhotra, Neal Chawla, Tanya Dorff, Tania Contente-Cuomo, Devin Dinwiddie, Bradon R. McDonald, Timothy McDaniel, Jeffrey M. Trent, Frederick L. Baehner, Muhammed Murtaza, Sumanta K. Pal
Publikováno v:
JCO Precision Oncology.
PURPOSE Circulating tumor DNA (ctDNA) has been validated across multiple indications in the adjuvant and surveillance settings. We evaluated whether targeted digital sequencing (TARDIS) may distinguish a partial response (PR) from a complete response
Autor:
Sumanta K. Pal, Neeraj Agarwal, Toni K. Choueiri, Divyam Goel, Nityam Rathi, Benjamin L. Maughan, Lesli Kiedrowski, Errol J. Philip, Neal Chawla, Jasnoor Malhotra, Sabrina Salgia, Ramya Muddasani, Alexander Chehrazi-Raffle, Luis Meza, Joann Hsu, Nazli Dizman, Nicholas J. Salgia, Caroline Weipert, Zeynep B. Zengin
Patient characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23f69e25dac01722c2843f97ae2d9161
https://doi.org/10.1158/1078-0432.22480646.v1
https://doi.org/10.1158/1078-0432.22480646.v1
Autor:
Sumanta K. Pal, Neeraj Agarwal, Toni K. Choueiri, Divyam Goel, Nityam Rathi, Benjamin L. Maughan, Lesli Kiedrowski, Errol J. Philip, Neal Chawla, Jasnoor Malhotra, Sabrina Salgia, Ramya Muddasani, Alexander Chehrazi-Raffle, Luis Meza, Joann Hsu, Nazli Dizman, Nicholas J. Salgia, Caroline Weipert, Zeynep B. Zengin
Change in alterations across time points
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a356febcfa85f54de1a458cf9aafc7e8
https://doi.org/10.1158/1078-0432.22480652.v1
https://doi.org/10.1158/1078-0432.22480652.v1
Autor:
Sumanta K. Pal, Neeraj Agarwal, Toni K. Choueiri, Divyam Goel, Nityam Rathi, Benjamin L. Maughan, Lesli Kiedrowski, Errol J. Philip, Neal Chawla, Jasnoor Malhotra, Sabrina Salgia, Ramya Muddasani, Alexander Chehrazi-Raffle, Luis Meza, Joann Hsu, Nazli Dizman, Nicholas J. Salgia, Caroline Weipert, Zeynep B. Zengin
Purpose:The role of circulating cell-free tumor DNA (ctDNA) as an adjunct to tissue genomic profiling is poorly defined in metastatic renal cell carcinoma (mRCC). In this study, we aim to validate previous findings related to genomic alteration (GA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0480fff840b8488b662c5df891a3c5f0
https://doi.org/10.1158/1078-0432.c.6530498
https://doi.org/10.1158/1078-0432.c.6530498